Giving Cells an Invisibility Cloak
The Context: Cell therapies hold enormous promise for treating many of today’s most devastating diseases, but for them to be effective, we have to ensure that...
The latest news and updates about NYSCF and our collaborators
The Context: Cell therapies hold enormous promise for treating many of today’s most devastating diseases, but for them to be effective, we have to ensure that...
Last week we hosted the 18th annual NYSCF Conference at The Rockefeller University, gathering over 500 international participants from academia, industry, government and nonprofits to engage...
NYSCF Principal Scientist Josephine (Josi) Wesely, PhD, was probably the only kid who showed up to her doctor’s appointments with scientific papers in hand. “I was...
The Context: When someone builds up excess fat around their liver, they can develop a condition called non-alcoholic fatty liver disease (NAFLD). Those with type 2...
This November, National Diabetes Month yielded some early holiday cheer as the FDA approved an exciting preventative treatment for type 1 diabetes (T1D). This work was...
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
Alzheimer’s, Parkinson’s, multiple sclerosis, cancer: they’re all diseases that are, to this day, largely a mystery, and treatment options are scarce. But thanks to stem cells,...
Annually for the past 15 years, the NYSCF Conference has showcased the latest cutting-edge findings in translational stem cell research, gathering world-renowned multi-disciplinary speakers and 500+...
NYSCF Board Member Kay Unger may be best known for her eponymous brand and trailblazing career in fashion, but she’s also an inspiring advocate for biomedical...
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
The Context: Organoids – 3D structures of human tissue derived from stem cells – are a critical tool for helping researchers study diseases like cancer and...
“How many people were promised a cure [for type 1 diabetes] within five or ten years?” JDRF CEO Aaron Kowalski asks the audience. Half the hands...
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
The Wall Street Journal profiled Susan L. Solomon, NYSCF CEO and Co-Founder. Part of the “Weekend Confidential” series, previously headlining Robert A.M. Stern, Tom Colicchio, and...